Liver stiffness and portal hypertension predict failure to DAA treatment in a real-life cohort of HCV-infected patients treated with recommended regimens. Issue 1 (16th February 2017) - Masetti, C.; De Leonardis, F.; Rossi, P.; Bosa, A.; Di Paolo, D.; Milana, M.; Santopaolo, F.; Pecchioli, A.; Di Nardi, S.; Francioso, S.; Lenci, I.; Baiocchi, L.; et al.